Cargando…
Clinical outcomes of endoscopic papillectomy of ampullary adenoma: A multi-center study
BACKGROUND: Ampullary adenoma is a rare premalignant lesion, but its incidence is increasing. Endoscopic papillectomy has become the first treatment of choice for ampullary adenomas due to its safety and effectiveness, thereby replacing surgical resection. However, recurrence rates and adverse event...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099193/ https://www.ncbi.nlm.nih.gov/pubmed/35633905 http://dx.doi.org/10.3748/wjg.v28.i17.1845 |
_version_ | 1784706549593145344 |
---|---|
author | Choi, Seong Ji Lee, Hong Sik Kim, Jiyeong Choe, Jung Wan Lee, Jae Min Hyun, Jong Jin Yoon, Jai Hoon Kim, Hyo Jung Kim, Jae Seon Choi, Ho Soon |
author_facet | Choi, Seong Ji Lee, Hong Sik Kim, Jiyeong Choe, Jung Wan Lee, Jae Min Hyun, Jong Jin Yoon, Jai Hoon Kim, Hyo Jung Kim, Jae Seon Choi, Ho Soon |
author_sort | Choi, Seong Ji |
collection | PubMed |
description | BACKGROUND: Ampullary adenoma is a rare premalignant lesion, but its incidence is increasing. Endoscopic papillectomy has become the first treatment of choice for ampullary adenomas due to its safety and effectiveness, thereby replacing surgical resection. However, recurrence rates and adverse events after endoscopic papillectomy were reported in up to 30% of cases. AIM: To review the long-term outcomes of endoscopic papillectomy and investigate the factors that affect these outcomes. METHODS: We retrospectively analyzed the data of patients who underwent endoscopic papillectomy for ampullary adenoma at five tertiary hospitals between 2013 and 2020. We evaluated clinical outcomes and their risk factors. The definitions of outcomes were as follow: (1) curative resection: complete endoscopic resection without recurrence; (2) endoscopic success: treatment of ampullary adenoma with endoscopy without surgical intervention; (3) early recurrence: reconfirmed adenoma at the first endoscopic surveillance; and (4) late recurrence: reconfirmed adenoma after the first endoscopic surveillance. RESULTS: A total of 106 patients were included for analysis. Of the included patients, 81 (76.4%) underwent curative resection, 99 (93.4%) had endoscopic success, showing that most patients with non-curative resection were successfully managed with endoscopy. Sixteen patients (15.1%) had piecemeal resection, 22 patients (20.8%) had shown positive/uncertain resection margin, 11 patients (16.1%) had an early recurrence, 13 patients (10.4%) had a late recurrence, and 6 patients (5.7%) had a re-recurrence. In multivariate analysis, a positive/uncertain margin [Odds ratio (OR) = 4.023, P = 0.048] and piecemeal resection (OR = 6.610, P = 0.005) were significant risk factors for early and late recurrence, respectively. Piecemeal resection was also a significant risk factor for non-curative resection (OR = 5.424, P = 0.007). Twenty-six patients experienced adverse events (24.5%). CONCLUSION: Endoscopic papillectomy is a safe and effective treatment for ampullary adenomas. Careful selection and follow-up of patients is mandatory, particularly in cases with positive/uncertain margin and piecemeal resection. |
format | Online Article Text |
id | pubmed-9099193 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-90991932022-05-26 Clinical outcomes of endoscopic papillectomy of ampullary adenoma: A multi-center study Choi, Seong Ji Lee, Hong Sik Kim, Jiyeong Choe, Jung Wan Lee, Jae Min Hyun, Jong Jin Yoon, Jai Hoon Kim, Hyo Jung Kim, Jae Seon Choi, Ho Soon World J Gastroenterol Retrospective Study BACKGROUND: Ampullary adenoma is a rare premalignant lesion, but its incidence is increasing. Endoscopic papillectomy has become the first treatment of choice for ampullary adenomas due to its safety and effectiveness, thereby replacing surgical resection. However, recurrence rates and adverse events after endoscopic papillectomy were reported in up to 30% of cases. AIM: To review the long-term outcomes of endoscopic papillectomy and investigate the factors that affect these outcomes. METHODS: We retrospectively analyzed the data of patients who underwent endoscopic papillectomy for ampullary adenoma at five tertiary hospitals between 2013 and 2020. We evaluated clinical outcomes and their risk factors. The definitions of outcomes were as follow: (1) curative resection: complete endoscopic resection without recurrence; (2) endoscopic success: treatment of ampullary adenoma with endoscopy without surgical intervention; (3) early recurrence: reconfirmed adenoma at the first endoscopic surveillance; and (4) late recurrence: reconfirmed adenoma after the first endoscopic surveillance. RESULTS: A total of 106 patients were included for analysis. Of the included patients, 81 (76.4%) underwent curative resection, 99 (93.4%) had endoscopic success, showing that most patients with non-curative resection were successfully managed with endoscopy. Sixteen patients (15.1%) had piecemeal resection, 22 patients (20.8%) had shown positive/uncertain resection margin, 11 patients (16.1%) had an early recurrence, 13 patients (10.4%) had a late recurrence, and 6 patients (5.7%) had a re-recurrence. In multivariate analysis, a positive/uncertain margin [Odds ratio (OR) = 4.023, P = 0.048] and piecemeal resection (OR = 6.610, P = 0.005) were significant risk factors for early and late recurrence, respectively. Piecemeal resection was also a significant risk factor for non-curative resection (OR = 5.424, P = 0.007). Twenty-six patients experienced adverse events (24.5%). CONCLUSION: Endoscopic papillectomy is a safe and effective treatment for ampullary adenomas. Careful selection and follow-up of patients is mandatory, particularly in cases with positive/uncertain margin and piecemeal resection. Baishideng Publishing Group Inc 2022-05-07 2022-05-07 /pmc/articles/PMC9099193/ /pubmed/35633905 http://dx.doi.org/10.3748/wjg.v28.i17.1845 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
spellingShingle | Retrospective Study Choi, Seong Ji Lee, Hong Sik Kim, Jiyeong Choe, Jung Wan Lee, Jae Min Hyun, Jong Jin Yoon, Jai Hoon Kim, Hyo Jung Kim, Jae Seon Choi, Ho Soon Clinical outcomes of endoscopic papillectomy of ampullary adenoma: A multi-center study |
title | Clinical outcomes of endoscopic papillectomy of ampullary adenoma: A multi-center study |
title_full | Clinical outcomes of endoscopic papillectomy of ampullary adenoma: A multi-center study |
title_fullStr | Clinical outcomes of endoscopic papillectomy of ampullary adenoma: A multi-center study |
title_full_unstemmed | Clinical outcomes of endoscopic papillectomy of ampullary adenoma: A multi-center study |
title_short | Clinical outcomes of endoscopic papillectomy of ampullary adenoma: A multi-center study |
title_sort | clinical outcomes of endoscopic papillectomy of ampullary adenoma: a multi-center study |
topic | Retrospective Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099193/ https://www.ncbi.nlm.nih.gov/pubmed/35633905 http://dx.doi.org/10.3748/wjg.v28.i17.1845 |
work_keys_str_mv | AT choiseongji clinicaloutcomesofendoscopicpapillectomyofampullaryadenomaamulticenterstudy AT leehongsik clinicaloutcomesofendoscopicpapillectomyofampullaryadenomaamulticenterstudy AT kimjiyeong clinicaloutcomesofendoscopicpapillectomyofampullaryadenomaamulticenterstudy AT choejungwan clinicaloutcomesofendoscopicpapillectomyofampullaryadenomaamulticenterstudy AT leejaemin clinicaloutcomesofendoscopicpapillectomyofampullaryadenomaamulticenterstudy AT hyunjongjin clinicaloutcomesofendoscopicpapillectomyofampullaryadenomaamulticenterstudy AT yoonjaihoon clinicaloutcomesofendoscopicpapillectomyofampullaryadenomaamulticenterstudy AT kimhyojung clinicaloutcomesofendoscopicpapillectomyofampullaryadenomaamulticenterstudy AT kimjaeseon clinicaloutcomesofendoscopicpapillectomyofampullaryadenomaamulticenterstudy AT choihosoon clinicaloutcomesofendoscopicpapillectomyofampullaryadenomaamulticenterstudy |